U.S. Spatial Genomics & Transcriptomics Market Size, Share & Trends Analysis Report By Technology (Spatial Transcriptomics, Spatial Genomics), By Product (Consumables, Software), By End-use, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Product
                        1.2.2. Technology
                        1.2.3. End-use
                        1.2.4. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                            1.4.5.1. Data for primary interviews
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Product
                        2.2.2. Technology
                        2.2.3. End-use
                    2.3. Competitive Insights
Chapter 3. Spatial Genomics & Transcriptomics Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                        3.2.2. Market Restraint Analysis
                    3.3. U.S. Spatial Genomics & Transcriptomics Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s Five Forces
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
Chapter 4. U.S. Spatial Genomics & Transcriptomics Market Product Estimates & Trend Analysis
                    4.1. U.S. Spatial Genomics & Transcriptomics Market Product Dashboard
                    4.2. U.S. Spatial Genomics & Transcriptomics Market Product Movement Analysis
                    4.3. U.S. Spatial Genomics & TranscriptomicsMarket Size & Forecasts And Trend Analyses, 2018 To 2030
                    4.4. Instruments
                        4.4.1. Instruments Market For Spatial Genomics & Transcriptomics, 2018 - 2030 (USD Million)
                        4.4.2. By Mode
                            4.4.2.1. Automated
                                4.4.2.1.1. Automated Market, 2018 - 2030 (USD Million)
                            4.4.2.2. Semi-Automated
                                4.4.2.2.1. Semi-Automated Market, 2018 - 2030 (USD Million)
                            4.4.2.3. Manual
                                4.4.2.3.1. Manual Market, 2018 - 2030 (USD Million)
                        4.4.3. By Type
                            4.4.3.1. Sequencing Platforms
                                4.4.3.1.1. Sequencing Platforms Market, 2018 - 2030 (USD Million)
                            4.4.3.2. IHC
                                4.4.3.2.1. IHC Market, 2018 - 2030 (USD Million)
                            4.4.3.3. Microscopy
                                4.4.3.3.1. Microscopy Market, 2018 - 2030 (USD Million)
                            4.4.3.4. Flow Cytometry
                                4.4.3.4.1. Flow Cytometry Market, 2018 - 2030 (USD Million)
                            4.4.3.5. Mass Spectrometry
                                4.4.3.5.1. Mass Spectrometry Market, 2018 - 2030 (USD Million)
                            4.4.3.6. Others
                                4.4.3.6.1. Others Market, 2018 - 2030 (USD Million)
                    4.5. Consumables
                        4.5.1. Consumables Market For Spatial Genomics & Transcriptomics, 2018 - 2030 (USD Million)
                    4.6. Software
                        4.6.1. Software Market For Spatial Genomics & Transcriptomics, 2018 - 2030 (USD Million)
                        4.6.2. Bioinformatics Tools
                            4.6.2.1. Bioinformatics Tools Market For Spatial Genomics & Transcriptomics, 2018 - 2030 (USD Million)
                        4.6.3. Imaging Tools
                            4.6.3.1. Imaging Tools Market For Spatial Genomics & Transcriptomics, 2018 - 2030 (USD Million)
                        4.6.4. Storage And Management Databases
                            4.6.4.1. Storage And Management Databases Market For Spatial Genomics & Transcriptomics, 2018 - 2030 (USD Million)
Chapter 5. U.S. Spatial Genomics & Transcriptomics Market: Technology Estimates & Trend Analysis
                    5.1. U.S. Spatial Genomics & Transcriptomics Market Technology Dashboard
                    5.2. U.S. Spatial Genomics & Transcriptomics Market Technology Movement Analysis
                    5.3. U.S. Spatial Genomics & Transcriptomics Market Size & Forecasts And Trend Analyses, 2018 To 2030
                    5.4. Spatial Transcriptomics
                        5.4.1. Spatial Transcriptomics Market, 2018 - 2030 (USD Million)
                        5.4.2. Sequencing-Based Methods
                            5.4.2.1. Sequencing-Based Methods Market, 2018 - 2030 (USD Million)
                            5.4.2.2. Laser Capture Microdissection (Lcm)
                                5.4.2.2.1. Lcm Market For Spatial Transcriptomics, 2018 - 2030 (USD Million)
                                5.4.2.2.2. LCM Using Ffpe Tissue Samples
                                    5.4.2.2.2.1. FFPE Tissue Samples-Based LCM Market For Spatial Transcriptomics, 2018 - 2030 (USD Million)
                                5.4.2.2.3. LCM Using Other Tissue Samples
                                    5.4.2.2.3.1. Other Tissue Samples-Based Lcm Market For Spatial Transcriptomics, 2018 - 2030 (USD Million)
                            5.4.2.3. Transcriptome In-Vivo Analysis (Tiva)
                                5.4.2.3.1. Tiva Market For Spatial Transcriptomics, 2018 - 2030 (USD Million)
                            5.4.2.4. In Situ Sequencing
                                5.4.2.4.1. In Situ Sequencing Market For Spatial Transcriptomics, 2018 - 2030 (USD Million)
                            5.4.2.5. Microtomy Sequencing
                                5.4.2.5.1. Microtomy Sequencing Market For Spatial Transcriptomics, 2018 - 2030 (USD Million)
                        5.4.3. IHC
                            5.4.3.1. IHC Market, 2018 - 2030 (USD Million)
                        5.4.4. Microscopy-based RNA imaging technique
                            5.4.4.1. microscopy-based RNA imaging techniques Market, 2018 - 2030 (USD Million)
                            5.4.4.2. Single Molecule RNA fluorescence In-Situ Hybridization (smFISH)
                                5.4.4.2.1. Single Molecule RNA fluorescence In-Situ Hybridization (smFISH) market for spatial transcriptomics, 2018 - 2030 (USD Million)
                            5.4.4.3. Padlock Probes/Rolling Circle Amplification
                                5.4.4.3.1. Padlock Probes/Rolling Circle Amplification market for spatial transcriptomics, 2018 - 2030 (USD Million)
                                5.4.4.3.2. Branched DNA Probes
                                5.4.4.3.3. Branched DNA probes market for spatial transcriptomics, 2018 - 2030 (USD Million)
                    5.5. Spatial Genomics
                        5.5.1. Spatial Genomics Market, 2018 - 2030 (USD Million)
                        5.5.2. FISH
                            5.5.2.1. FISH Market for Spatial Genomics, 2018 - 2030 (USD Million)
                        5.5.3. Microscopy-based Live DNA Imaging
                            5.5.3.1. Microscopy-based Live DNA Imaging Market for Spatial Genomics, 2018 - 2030 (USD Million)
                        5.5.4. Genome Perturbation tools
                            5.5.4.1. genome perturbation tools Market for spatial genomics, 2018 - 2030 (USD Million)
                        5.5.5. Massively-Parallel Sequencing
                            5.5.5.1. massively-parallel sequencing Market for spatial genomics, 2018 - 2030 (USD Million)
                        5.5.6. Biochemical Techniques
                            5.5.6.1. biochemical techniques Market for spatial genomics, 2018 - 2030 (USD Million)
                        5.5.7. Others
                            5.5.7.1. others Market for spatial genomics, 2018 - 2030 (USD Million)
Chapter 6. U.S. Spatial Genomics & Transcriptomics Market: End-use Estimates & Trend Analysis
                    6.1. U.S. Spatial Genomics & Transcriptomics Market End-use Dashboard
                    6.2. U.S. Spatial Genomics & Transcriptomics Market End-use Movement Analysis
                    6.3. U.S. Spatial Genomics & Transcriptomics Market Size & Forecasts and Trend Analyses, 2018 to 2030
                        6.3.1. Translational Research
                            6.3.1.1. Translational Research Market, 2018 - 2030 (USD Million)
                        6.3.2. Academic Customers
                            6.3.2.1. Academic CustomersMarket, 2018 - 2030 (USD Million)
                        6.3.3. Diagnostic Customers
                            6.3.3.1. Diagnostic Customers Market, 2018 - 2030 (USD Million)
                        6.3.4. Pharmaceutical Manufacturer
                            6.3.4.1. Pharmaceutical Manufacturer Market, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Recent Developments & Impact Analysis, By Key Market Participants
                    7.2. Company/Competition Categorization
                    7.3. Vendor Landscape
                        7.3.1. List of key distributors and channel partners
                        7.3.2. Key customers
                        7.3.3. Key company market share analysis, 2023
                            7.3.3.1. Company overview
                            7.3.3.2. Financial performance
                            7.3.3.3. Product benchmarking
                            7.3.3.4. Strategic initiatives
                        7.3.4. Thermo Fisher Scientific, Inc.
                            7.3.4.1. Company overview
                            7.3.4.2. Financial performance
                            7.3.4.3. Product benchmarking
                            7.3.4.4. Strategic initiatives
                        7.3.5. New England Biolabs
                            7.3.5.1. Company overview
                            7.3.5.2. Financial performance
                            7.3.5.3. Product benchmarking
                            7.3.5.4. Strategic initiatives
                        7.3.6. Danaher
                            7.3.6.1. Company overview
                            7.3.6.2. Financial performance
                            7.3.6.3. Product benchmarking
                            7.3.6.4. Strategic initiatives
                        7.3.7. New England Biolabs
                            7.3.7.1. Company overview
                            7.3.7.2. Financial performance
                            7.3.7.3. Product benchmarking
                            7.3.7.4. Strategic initiatives
                        7.3.8. Bruker
                            7.3.8.1. Company overview
                            7.3.8.2. Financial performance
                            7.3.8.3. Product benchmarking
                            7.3.8.4. Strategic initiatives
                        7.3.9. Agilent Technologies
                            7.3.9.1. Company overview
                            7.3.9.2. Financial performance
                            7.3.9.3. Product benchmarking
                            7.3.9.4. Strategic initiatives
                        7.3.10. Waters Corporation
                            7.3.10.1. Company overview
                            7.3.10.2. Financial performance
                            7.3.10.3. Product benchmarking
                            7.3.10.4. Strategic initiatives
                        7.3.11. Creative Proteomics
                            7.3.11.1. Company overview
                            7.3.11.2. Financial performance
                            7.3.11.3. Product benchmarking
                            7.3.11.4. Strategic initiatives
                        7.3.12. BioAge Labs
                            7.3.12.1. Company overview
                            7.3.12.2. Financial performance
                            7.3.12.3. Product benchmarking
                            7.3.12.4. Strategic initiatives
                        7.3.13. Frontier Medicines
                            7.3.13.1. Company overview
                            7.3.13.2. Financial performance
                            7.3.13.3. Product benchmarking
                            7.3.13.4. Strategic initiatives
                        7.3.14. Monte Rose Therapeutics
                            7.3.14.1. Company overview
                            7.3.14.2. Financial performance
                            7.3.14.3. Product benchmarking
                            7.3.14.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 U.S. Spatial Genomics & Transcriptomics Market, Product, 2018 - 2030 (USD Billion)
Table 3 U.S. Spatial Genomics & Transcriptomics Market, Technology, 2018 - 2030 (USD Billion)
Table 4 U.S. Spatial Genomics & Transcriptomics Market, End-use, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Spatial Genomics & Transcriptomics genes market segmentation
Fig. 8 Market snapshot, 2023
Fig. 9 Market Trends & outlook
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 PESTEL analysis
Fig. 13 Porter’s Five Forces analysis
Fig. 14 U.S. Spatial Genomics & Transcriptomics Market: Product outlook and key takeaways
Fig. 15 U.S. Spatial Genomics & Transcriptomics Market: Product movement analysis & market share 2023 & 2030
Fig. 16 Instruments, Market, 2018 - 2030 (USD Million)
Fig. 17 Automated Market, 2018 - 2030 (USD Million)
Fig. 18 Semi-Automated Market, 2018 - 2030 (USD Million)
Fig. 19 Manual, Market, 2018 - 2030 (USD Million)
Fig. 20 Sequencing Platforms Market, 2018 - 2030 (USD Million)
Fig. 21 IHC Market, 2018 - 2030 (USD Million)
Fig. 22 Microscopy Market, 2018 - 2030 (USD Million)
Fig. 23 Flow Cytometry Kits Market, 2018 - 2030 (USD Million)
Fig. 24 Mass Spectrometry Kits Market, 2018 - 2030 (USD Million)
Fig. 25 Others Market, 2018 - 2030 (USD Million)
Fig. 26 Consumables Market, 2018 - 2030 (USD Million)
Fig. 27 Software Market, 2018 - 2030 (USD Million)
Fig. 28 Bioinformatics Tools Market, 2018 - 2030 (USD Million)
Fig. 29 Imaging Tools Market, 2018 - 2030 (USD Million)
Fig. 30 Storage And Management Databases Market, 2018 - 2030 (USD Million)
Fig. 31 U.S. Spatial Genomics & Transcriptomics Market: Technology outlook and key takeaways
Fig. 32 U.S. Spatial Genomics & Transcriptomics Market: Technology movement analysis & market share 2023 & 2030
Fig. 33 Spatial Transcriptomics Market, 2018 - 2030 (USD Million)
Fig. 34 Sequencing - Based methods market, 2018 - 2030 (USD Million)
Fig. 35 LCM Methods market, 2018 - 2030 (USD Million)
Fig. 36 Fig Fig FFPE tissue samples market, 2018 - 2030 (USD Million)
Fig. 37 Fig Fig Other Laser Capture Microdissection Market, 2018 - 2030 (USD Million)
Fig. 38 TIVA market, 2018 - 2030 (USD Million)
Fig. 39 In-Situ- Situ Sequencing Market, 2018 - 2030 (USD Million)
Fig. 40 Microtomy sequencing market, 2018 - 2030 (USD Million)
Fig. 41 IHC sequencing market, 2018 - 2030 (USD Million)
Fig. 42 Microscopyoscopy - based RNA imaging technologies market, 2018 - 2030 (USD Million)
Fig. 43 smFISH market, 2018 - 2030 (USD Million)
Fig. 44 Padlock Probes/Rolling Circle Amplification Market, 2018 - 2030 (USD Million)
Fig. 45 Branched DNA Probes Market, 2018 - 2030 (USD Million)
Fig. 46 Spatial Genomics market, 2018 - 2030 (USD Million)
Fig. 47 FISH, market, 2018 - 2030 (USD Million)
Fig. 48 Microscopy-Based Based Live DNA Imaging Market, 2018 - 2030 (USD Million)
Fig. 49 Genome Perturbation Tools Market, 2018 - 2030 (USD Million)
Fig. 50 Massively - Parallel Sequencing Market, 2018 - 2030 (USD Million)
Fig. 51 Biochemical Techniques Market, 2018 - 2030 (USD Million)
Fig. 52 Other Spatial Genomic Technique Market, 2018 - 2030 (USD Million)
Fig. 53 U.S. Spatial Genomics & Transcriptomics Market: End-use outlook and key takeaways
Fig. 54 U.S. Spatial Genomics & Transcriptomics Market: End-use movement analysis & market share 2023 & 2030
Fig. 55 Translational Research Market, 2018 - 2030 (USD Million)
Fig. 56 Academic Customers Market, 2018 - 2030 (USD Million)
Fig. 57 Diagnostic Customers Companies Market, 2018 - 2030 (USD Million)
Fig. 58 Pharmaceutical Manufacturer market, 2018 - 2030 (USD Million)